The audiogram: Detection of pure-tone stimuli in ototoxicity monitoring and assessments of investigational medicines for the inner ear
- PMID: 35931504
- PMCID: PMC9288270
- DOI: 10.1121/10.0011739
The audiogram: Detection of pure-tone stimuli in ototoxicity monitoring and assessments of investigational medicines for the inner ear
Abstract
Pure-tone thresholds have long served as a gold standard for evaluating hearing sensitivity and documenting hearing changes related to medical treatments, toxic or otherwise hazardous exposures, ear disease, genetic disorders involving the ear, and deficits that develop during aging. Although the use of pure-tone audiometry is basic and standard, interpretation of thresholds obtained at multiple frequencies in both ears over multiple visits can be complex. Significant additional complexity is introduced when audiometric tests are performed within ototoxicity monitoring programs to determine if hearing loss occurs as an adverse reaction to an investigational medication and during the design and conduct of clinical trials for new otoprotective agents for noise and drug-induced hearing loss. Clinical trials using gene therapy or stem cell therapy approaches are emerging as well with audiometric outcome selection further complicated by safety issues associated with biological therapies. This review addresses factors that must be considered, including test-retest variability, significant threshold change definitions, use of ototoxicity grading scales, interpretation of early warning signals, measurement of notching in noise-induced hearing loss, and application of age-based normative data to interpretation of pure-tone thresholds. Specific guidance for clinical trial protocols that will assure rigorous methodological approaches and interpretable audiometric data are provided.
Figures

Similar articles
-
Factors affecting sensitivity of distortion-product otoacoustic emissions to ototoxic hearing loss.Ear Hear. 2008 Dec;29(6):875-93. doi: 10.1097/AUD.0b013e318181ad99. Ear Hear. 2008. PMID: 18753950 Clinical Trial.
-
Pure-Tone Audiometry With Forward Pressure Level Calibration Leads to Clinically-Relevant Improvements in Test-Retest Reliability.Ear Hear. 2018 Sep/Oct;39(5):946-957. doi: 10.1097/AUD.0000000000000555. Ear Hear. 2018. PMID: 29470259
-
Frequency and Patterns of Hearing Dysfunction in Patients Treated with Teprotumumab.Ophthalmology. 2024 Jan;131(1):30-36. doi: 10.1016/j.ophtha.2023.08.001. Epub 2023 Aug 9. Ophthalmology. 2024. PMID: 37567417 Review.
-
Otitis media with effusion in children: Cross-frequency correlation in pure tone audiometry.PLoS One. 2019 Aug 22;14(8):e0221405. doi: 10.1371/journal.pone.0221405. eCollection 2019. PLoS One. 2019. PMID: 31437206 Free PMC article.
-
Prevention of Noise-Induced Hearing Loss Using Investigational Medicines for the Inner Ear: Previous Trial Outcomes Should Inform Future Trial Design.Antioxid Redox Signal. 2022 Jun;36(16-18):1171-1202. doi: 10.1089/ars.2021.0166. Epub 2021 Oct 4. Antioxid Redox Signal. 2022. PMID: 34346254 Free PMC article. Review.
Cited by
-
Evaluation of hidden hearing loss in normal-hearing firearm users.Front Neurosci. 2022 Oct 26;16:1005148. doi: 10.3389/fnins.2022.1005148. eCollection 2022. Front Neurosci. 2022. PMID: 36389238 Free PMC article.
-
Noise-induced hearing disorders: Clinical and investigational tools.J Acoust Soc Am. 2023 Jan;153(1):711. doi: 10.1121/10.0017002. J Acoust Soc Am. 2023. PMID: 36732240 Free PMC article.
-
Effects of Stimulus Type on 16-kHz Detection Thresholds.Ear Hear. 2024 Mar-Apr 01;45(2):486-498. doi: 10.1097/AUD.0000000000001446. Epub 2024 Jan 5. Ear Hear. 2024. PMID: 38178308 Free PMC article.
-
U.S. Population Data on Hearing Loss, Trouble Hearing, and Hearing-Device Use in Adults: National Health and Nutrition Examination Survey, 2011-12, 2015-16, and 2017-20.Trends Hear. 2023 Jan-Dec;27:23312165231160978. doi: 10.1177/23312165231160978. Trends Hear. 2023. PMID: 37016920 Free PMC article.
-
Report of a SPEAC webinar 22 september 2023: Sensorineural hearing loss, lassa virus disease and vaccines.Vaccine. 2025 Jan 1;43(Pt 1):126525. doi: 10.1016/j.vaccine.2024.126525. Epub 2024 Nov 22. Vaccine. 2025. PMID: 39579650 Review.
References
-
- Agrawal, Y. , Platz, E. A. , and Niparko, J. K. (2008). “ Prevalence of hearing loss and differences by demographic characteristics among US adults: Data from the National Health and Nutrition Examination Survey, 1999–2004,” Arch. Intern. Med. 168, 1522–1530.10.1001/archinte.168.14.1522 - DOI - PubMed
-
- American Academy of Audiology (2009). “Position statement and clinical practice guidelines: Ototoxicity monitoring,” available at https://www.audiology.org/practice-resources/practice-guidelines-and-sta... (Last viewed July 12, 2021).
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources